Cancer Drug Trial
- All
- News
-
Hope For Cancer Patients, New Treatment Strategy Targets Rogue DNA
The research, which analyzed data from over 15,000 UK cancer patients, identifies ecDNA as a key factor in cancer progression and drug resistance.
-
New Hope For Bowel Cancer: Immunotherapy Drug Offers Cure Without Surgery
A groundbreaking immunotherapy drug, Pembrolizumab (Keytruda), shows promising results in treating bowel cancer by targeting specific immune cell proteins.
-
Child With Rare Brain Cancer Experiences Significant Improvement After Treatment
Lucas and his family travelled from Belgium to France so that he could become one of the first patients to join the BIOMEDE trial, which tests potential new drugs for DIPG.
-
Promising New Treatment Boosts Survival Rates In Pediatric Cancer
The approach targets neuroblastomas, a rare form of cancer which develops in nerve cells.
-
Indian-Origin Woman Given Months To Live Now Cancer-Free After Drug Trial In UK
An Indian-origin woman, Jasmin David, who was given just months to live a few years ago is showed no evidence of breast cancer following a successful National Health Service (NHS) trial, doctors said.
-
10 Points On Dostarlimab, The Drug That 'Cured' Cancer During Trials
A study has found that a drug named Dostarlimab has helped treat rectal cancer. This has been described as a "first time in history"kind of result in cancer treatment with the disease simply vanishing in patients after the experimental treatment.
-
Cancer Disappears From Every Patient's Body In Drug Trial In US: Report
A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic.
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
-
"First Time In History": Cancer Vanishes For Every Patient In Drug Trial
A small group of people with rectal cancer just experienced something of a miracle as their cancer simply vanished after an experimental treatment.
-
FDA Approves New Drug For Leukemia
AML is a rapidly progressing cancer that crowds out normal cells in the bone marrow and bloodstream, resulting in low numbers of normal blood cells and a continuous need for transfusions, reports Xinhua news agency.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
Lung Cancer Drug Trials Made More Successful
By mimicking the complexity of human tumors with a research tool, the scientists were able to identify a "biomarker" which could serve as an indication as to which patients would better respond to certain drugs, Xinhua news agency reported.
-
Drug Combo Cuts Breast Cancer Deaths In Key Trial
Combining Roche's Perjeta and Herceptin drugs with chemotherapy reduced recurrence of aggressive breast cancer or death compared to Herceptin and chemo, the Swiss drugmaker said on Thursday.
-
FDA Lifts Hold On Astrazeneca Head And Neck Cancer Trials
The British drugmaker said on Tuesday that one of the late-stage Phase III trials had already re-opened for new patient enrolment and the second was expected to resume recruitment shortly.
-
Biocon Hits 52-Week High On Positive Trial Results Of Cancer Drug
Analysts say the new drug could be a big revenue opportunity for Biocon.
-
Hope For Cancer Patients, New Treatment Strategy Targets Rogue DNA
The research, which analyzed data from over 15,000 UK cancer patients, identifies ecDNA as a key factor in cancer progression and drug resistance.
-
New Hope For Bowel Cancer: Immunotherapy Drug Offers Cure Without Surgery
A groundbreaking immunotherapy drug, Pembrolizumab (Keytruda), shows promising results in treating bowel cancer by targeting specific immune cell proteins.
-
Child With Rare Brain Cancer Experiences Significant Improvement After Treatment
Lucas and his family travelled from Belgium to France so that he could become one of the first patients to join the BIOMEDE trial, which tests potential new drugs for DIPG.
-
Promising New Treatment Boosts Survival Rates In Pediatric Cancer
The approach targets neuroblastomas, a rare form of cancer which develops in nerve cells.
-
Indian-Origin Woman Given Months To Live Now Cancer-Free After Drug Trial In UK
An Indian-origin woman, Jasmin David, who was given just months to live a few years ago is showed no evidence of breast cancer following a successful National Health Service (NHS) trial, doctors said.
-
10 Points On Dostarlimab, The Drug That 'Cured' Cancer During Trials
A study has found that a drug named Dostarlimab has helped treat rectal cancer. This has been described as a "first time in history"kind of result in cancer treatment with the disease simply vanishing in patients after the experimental treatment.
-
Cancer Disappears From Every Patient's Body In Drug Trial In US: Report
A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic.
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
-
"First Time In History": Cancer Vanishes For Every Patient In Drug Trial
A small group of people with rectal cancer just experienced something of a miracle as their cancer simply vanished after an experimental treatment.
-
FDA Approves New Drug For Leukemia
AML is a rapidly progressing cancer that crowds out normal cells in the bone marrow and bloodstream, resulting in low numbers of normal blood cells and a continuous need for transfusions, reports Xinhua news agency.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
Lung Cancer Drug Trials Made More Successful
By mimicking the complexity of human tumors with a research tool, the scientists were able to identify a "biomarker" which could serve as an indication as to which patients would better respond to certain drugs, Xinhua news agency reported.
-
Drug Combo Cuts Breast Cancer Deaths In Key Trial
Combining Roche's Perjeta and Herceptin drugs with chemotherapy reduced recurrence of aggressive breast cancer or death compared to Herceptin and chemo, the Swiss drugmaker said on Thursday.
-
FDA Lifts Hold On Astrazeneca Head And Neck Cancer Trials
The British drugmaker said on Tuesday that one of the late-stage Phase III trials had already re-opened for new patient enrolment and the second was expected to resume recruitment shortly.
-
Biocon Hits 52-Week High On Positive Trial Results Of Cancer Drug
Analysts say the new drug could be a big revenue opportunity for Biocon.
